Premium
BeyondSpring Inc (BYSI)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities... BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China. Show more
FLORHAM PARK, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company developing innovative...
FLORHAM PARK, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company developing innovative...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1257 | -7.15953750641 | 1.7557 | 1.7557 | 1.5601 | 21285 | 1.61875376 | CS |
| 4 | -0.1391 | -7.8627550732 | 1.7691 | 1.8556 | 1.43 | 34005 | 1.62266675 | CS |
| 12 | -0.8 | -32.9218106996 | 2.43 | 2.53 | 1.43 | 24878 | 1.79930465 | CS |
| 26 | -0.71 | -30.3418803419 | 2.34 | 2.6 | 1.43 | 25275 | 1.99315352 | CS |
| 52 | 0.73 | 81.1111111111 | 0.9 | 4 | 0.7777 | 81921 | 2.56073455 | CS |
| 156 | -2.98 | -64.6420824295 | 4.61 | 5.175 | 0.542 | 228472 | 2.1532443 | CS |
| 260 | -13.79 | -89.4293125811 | 15.42 | 33 | 0.542 | 456138 | 13.14811705 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
